Description: This presentation is a panel discussion, session 54PD, from the 2004 Spring Meeting of the Society of Actuaries, held June 14-15 in San Antonio, TX. This session covers the impact of segmentation and underwriting on expected mortality and morbidity. Panelists discuss the importance of data mining and customer selection on ultimate experience, setting up direct marketing applications with the right type of questions to maximize responses but limit risk, the use of prescription drugs and other databases, and industry practices for obtaining customer information. Discussion from participants is included. From the Record of Society of Actuaries, Volume 30, No. 2.

Description: This paper considers recent accidental death mortality experience applicable to both ordinary life policies and other accident products, presents a possible new valuation accidental death benefits mortality table for U.S. business, and provides several sources for actuaries interested in more information about accidental death mortality.

Description: Sponsored by the SOA's Product Development Section, Financial Reporting Section, Committee on Life Insurance Research and the Canadian Institute of Actuaries, this report examines the application of credibility theory in the Canadian life insurance industry.

Description: This report examines options for analyzing periodic changes in VM-20 reserve amounts.

Description: Non-guaranteed elements are parameters of life insurance and annuity polices that are not fixed when the policy is issued but may be changed from time to time by the insurance company.

Description: The Individual Life Experience Committee is holding a competition encouraging actuaries and other interested parties to predict 2017 industry mortality based on a data set containg 2009 - 2016 data. The competition is not only about predicting mortality, but also about explaining and presenting the results.

Description: Examines complex structured assets used by life and annuity insurers, including structures, risks, performance in crises, and implications for capital and asset-liability management.

Description: Initiated by the Product Development Section, this report examines global product development (PD) practices of life insurance and annuity companies.

Description: This research report examines the ban of the use of genetic testing information in life insurance mortality.

Description: This report is presented in the form of a Tableau dashboard and is the sixth public release from this report series and contains the results of an excess mortality analysis for the fourth quarter of 2021. Data from 30 companies representing approximately 69% of the industry’s face amount inforce were included in the analyses in this report. A total of 3.2 million death claims from individual life policies from 2015 through December 31, 2021 make up the basis of the analyses. The report also compares the experience under COVID-19 of the insured population versus the general population.